Breaking News

Trials & Filings in Brief: Nov. 20, 2013

By Gil Roth | November 20, 2013

Advaxis, Amgen, Cornerstone CytRx, Daiichi Sankyo, Genzyme, Sanofi, Zealand

Phase II
Advaxis starts HPV cancer trial . . . read more

Amgen presents PCSK9 LDL results . . . read more

CytRx starts GBM trial . . . read more

Zealand begins danegaptide POC trial . . . read more

Phase III
Daiichi's edoxaban exceeds warfarin targets . . . read more

Filings
Health Canada approves Sanofi's Aubagio . . . read more

Launches
Cornerstone launches Bethkis for CF . . . read more

blog comments powered by Disqus